Contact Information
Email
a****@dewpointtherapeutics.com
Unlock
Company Information
Company
Dewpoint Therapeutics
Annual Revenue
10000000.0
Total Funding
287000000.0
Technologies
Outlook
MailChimp SPF
Microsoft Office 365
Greenhouse.io
Google Cloud Hosting
Render
AI
Keywords
biomolecular condensates
oncology
neurodegeneration
cardiopulmonary
virology
insulin resistance
rare disease
biotechnology research
drug discovery
therapeutic area
integrated discovery platform
ai platform
phase separation
druggable targets
cancer treatment
neurodegenerative diseases
metabolic diseases
cardiovascular diseases
collaborative partnerships
therapeutic pipeline
modulating condensates
condensate-modifying drugs
c-mods
precision medicine
high-throughput screening
novel therapies
target validation
cellular biology
disease modeling
protein aggregation
biotech collaborations
investment funding
patented technologies
multi-disciplinary research
threshold technology
genetic profiling
pharmaceutical partnerships
digital platform
molecular communities
research & development
clinical candidates
cross-functional teams
quantitative analysis
high-content imaging
compound library
patient-centered drug development
science of condensates
molecular mechanisms
disease pathophysiology
disruptive innovation
target identification
next generation therapeutics
research collaborations
drug optimization
biotechnology
ai technology
preclinical programs
partnerships
pharmaceutical collaborations
novel therapeutics
complex diseases
drug development
healthcare providers
patient advocacy
scientific leadership
innovative research
condensate biology
high unmet needs
drug targets
rare diseases
als
colorectal cancer
small-molecule drugs
strategic partnerships
funding rounds
intellectual property
scientific advisory board
emerging science
drug discovery platforms
energy-efficient facilities
boston
dresden
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans